Cytokinetics is up a bit on the day, funds flowing in kept the price up 2.78% since yesterday.
Currently CYTK isn't at a clear support/resistance line that seems tradable. CYTK hasn't established a very clear directional momentum over the last few months. So it's not clear exactly where it's going. CYTK might find some support at the 46.38 level, buyers might push the price back up from here. But it's not very clear what will happen.
Analysts currently have an extremely positive outlook for Cytokinetics. This normally relates to positive future price increases, especially on pullbacks. The current Analysts Sentiment Score is 357.21. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2023-03-07 and they set their price target at $61.00. Mizuho initiated a rating of Buy on 2023-03-06 and added a price target of $80.00. On 2023-03-02 The Goldman Sachs Group lowered their price target by -14.29% to $48.00. JMP Securities reiterated a rating of Buy on 2023-03-02 and added a price target of $71.00. Oppenheimer announced a lowering of their price target to $54.00 from $55.00 on 2023-03-01. Needham & Company LLC announced that they are reiterating a rating of Buy on 2023-03-01 and they set their price target at $58.00. Bank of America announced that they are initiating coverage with a rating of Neutral on 2023-02-17 and added a price target of $49.00. On 2022-12-20 Truist Financial started covering Cytokinetics with a rating of Buy and added a price target of $60.00. HC Wainwright gave a boost to their price target and moved to $56.00 from $29.00 on 2022-12-15. On 2022-12-15 UBS Group lowered their price target by -17.5% to $66.00.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
CYTK | 357.21 | 367.43 | 0 | 393.96 | -46.98 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
CYTK | -53.52 | -6.14 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
CYTK | 11 | %13.5193 | 9.9 | -9.834 | 11340000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 367 | 1.85 | -0.88 | -10.56 | 1.85 | -7.04 | -22.15 | 31.57 | -13.77 | -17.27 | -13.81 | -41814.93 | -3164.24 | 0.95 | 21.19 | 6.54 | 48.84 |
Healthcare | 617 | 2.00 | -0.17 | -8.49 | 2.07 | -6.13 | -23.93 | 31.85 | -11.33 | -14.45 | -14.07 | -36805.91 | -4054.41 | 1.05 | 22.33 | 5.93 | 36.37 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
CYTK | 2.00 |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DNLI | Denali Therapeutics Inc. | 0.74 | -0.30 | -2.35 | -20.42 | -19.99 | -19.38 | -30.23 | 15 | -14.17 | -11.37 | -5.44 | -17869.11 | -140.02 | 0 | 0 | 7.15982 |
IMGN | Immunogen Inc | 0.66 | 0.25 | -3.90 | -0.25 | -15.81 | -21.83 | -8.37 | 46 | -52.79 | -22.23 | -15.61 | -18131.34 | 170.62 | 0 | 0 | 5.13712 |
ARWR | Arrowhead Research Corpor | 0.57 | -1.84 | -2.84 | -25.11 | -35.62 | -27.30 | -45.81 | 4 | -11.76 | -20.65 | -18.17 | -34746.31 | 0.00 | 0 | 150 | 4.85006 |
RCKT | Rocket Pharmaceuticals, I | 0.57 | 1.13 | -0.78 | -6.93 | -6.93 | 30.53 | 18.19 | 32 | 14.11 | 27.18 | 37.50 | -3220.62 | -6047.37 | 0 | 0 | 8.14334 |
NTLA | Intellia Therapeutics, In | 0.56 | 3.97 | -2.67 | 2.18 | 10.31 | -36.37 | -43.12 | 39 | -8.64 | -26.94 | -25.79 | -42061.90 | -491.01 | 0 | 0 | 6.34434 |
SGMO | Sangamo Therapeutics, Inc | 0.55 | -1.55 | -12.04 | -34.71 | -39.49 | -64.15 | -67.13 | 9 | -49.80 | -90.58 | -41.56 | -39882.11 | 0.00 | 0 | 0 | 8.30077 |
SAGE | Sage Therapeutics, Inc | 0.54 | -1.57 | -0.07 | 2.61 | 8.22 | 4.92 | 28.84 | 54 | 20.13 | 16.62 | 33.67 | -4282.46 | -5290.62 | 0 | 0 | 8.58313 |
ZS | Zscaler, Inc. Common Stoc | 0.54 | 7.17 | 4.97 | -14.48 | 3.35 | -34.55 | -48.83 | 22 | -23.43 | -30.26 | -38.01 | -30161.21 | -336.01 | 0 | 0 | 7.61717 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.